-
Immunocore Holdings plc (IMCR) Tops Q3 EPS by 24c
-
Wells Fargo Starts Immunocore Holdings (IMCR) at Overweight
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
Jefferies Assumes Immunocore Holdings (IMCR) at Buy
-
Immunocore Holdings plc (IMCR) Misses Q2 EPS by 2c
-
Immunocore Holdings (IMCR) PT Raised to $36 at Mizuho
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
Deutsche Bank Starts Immunocore Holdings (IMCR) at Buy
-
Immunocore Holdings plc (IMCR) Tops Q1 EPS by 49c
-
Immunocore Holdings (IMCR) PT Lowered to $33 at Mizuho
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
BTIG Reiterates Buy Rating on Immunocore Holdings (IMCR), PT $91
-
Immunocore (IMCR) presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
-
Immunocore Holdings plc (IMCR) Misses Q4 EPS by 23c
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
Immunocore (IMCR) announces strategic priorities
-
Immunocore (IMCR) appoints Travis Coy as CFO, Head of Corporate Development
-
Immunocore (IMCR) announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
-
Morgan Stanley Downgrades Immunocore Holdings (IMCR) to Equalweight
-
Immunocore (IMCR) announces reimbursement agreement in England for KIMMTRAK for the treatment of HLA-A*02:01-positive adults
-
Mizuho Downgrades Immunocore Holdings (IMCR) to Neutral
-
Immunocore Holdings plc (IMCR) Tops Q3 EPS by 50c
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
UBS Starts Immunocore Holdings (IMCR) at Sell
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
Oppenheimer Reiterates Outperform Rating on Immunocore Holdings (IMCR)
-
TD Cowen Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
Mizuho Reiterates Outperform Rating on Immunocore Holdings (IMCR)
-
Immunocore (IMCR) Announces CFO Transition
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
Immunocore Holdings (IMCR) PT Lowered to $72 at Mizuho
-
Immunocore Holdings plc (IMCR) Tops Q2 EPS by 25c

